Results
|
|
301.
|
|
|
|
302.
|
|
|
|
303.
|
|
|
|
304.
|
|
|
|
305.
|
|
|
|
306.
|
|
|
|
307.
|
|
|
|
308.
|
|
|
|
309.
|
|
|
|
310.
|
|
|
|
311.
|
|
|
|
312.
|
|
|
|
313.
|
|
|
|
314.
|
|
|
|
315.
|
|
|
|
316.
|
|
|
|
317.
|
|
|
|
318.
|
|
|
|
319.
|
Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives. [electronic resource] by
- Hümpel, M
- Täuber, U
- Kuhnz, W
- Pfeffer, M
- Brill, K
- Heithecker, R
- Louton, T
- Steinberg, B
- Seifert, W
- Schütt, B
Producer: 19900822
In:
American journal of obstetrics and gynecology vol. 163
Availability: No items available.
|
|
|
320.
|
|